Medical genetics is the branch of medicine focused on diagnosing, managing, and treating conditions caused by changes in a person’s DNA or chromosomes. It covers everything from rare inherited diseases in newborns to the genetic factors behind common conditions like heart disease and diabetes. Unlike many medical specialties that focus on a single organ system, medical genetics cuts across the entire body, because genes influence virtually every aspect of health.
Types of Genetic Disorders
Genetic conditions generally fall into three broad categories, each with different causes and patterns.
Single-gene disorders result from a change in one specific gene. These include well-known conditions like cystic fibrosis, sickle cell disease, and hemophilia. Because a single gene is responsible, these conditions often follow predictable inheritance patterns, meaning families can sometimes anticipate the risk of passing them on.
Chromosomal abnormalities involve larger-scale changes to the structures that package your DNA. Having an extra copy of a chromosome (trisomy), a missing chromosome (monosomy), or a segment that’s been deleted, flipped, or relocated to the wrong chromosome can all cause health problems. Down syndrome, caused by an extra copy of chromosome 21, is one of the most recognized examples.
Complex (multifactorial) conditions are the most common category and involve changes across many different genes interacting with environmental factors like diet, physical activity, pollution exposure, and smoking. Heart disease, type 2 diabetes, and many cancers fall into this group. Because so many variables contribute, these conditions don’t follow simple inheritance patterns, though they do tend to run in families.
What Happens at a Genetics Appointment
A genetics evaluation follows a fairly structured path. At your first visit, a genetic counselor or genetics resident will do an extensive review of both your personal medical history and your family’s medical history, often drawing out a detailed family tree going back several generations. You’ll also have a standard physical exam, since many genetic conditions have subtle physical features that a trained geneticist can recognize.
From there, the team decides which tests and evaluations will be most useful. This might include genetic testing, imaging studies, or referrals to other specialists. Genetic test results typically take six to eight weeks, though some come back in as little as one week and others take up to twelve. At a follow-up visit, the team reviews what the results mean for you and your family, and lays out a plan that might include additional specialists, treatments, or monitoring. Most genetics teams recommend follow-up appointments every one to two years after that.
Genetic Testing Technologies
The tools available to diagnose genetic conditions have expanded dramatically. Two of the most powerful are whole exome sequencing, which reads the roughly 1-2% of your genome that codes for proteins, and whole genome sequencing, which reads essentially all of your DNA. Both are effective as first-line tests, with diagnostic yields ranging from 16% to 56% depending on the patient group and what testing has already been done. That may not sound high, but for families who have spent years searching for a diagnosis, even a 16% chance of finally getting an answer is significant.
When whole exome sequencing comes back negative, whole genome sequencing can still identify a diagnosis in an additional 7% to 30% of cases, because it captures genetic changes outside the protein-coding regions. Perhaps most importantly, getting a genetic diagnosis isn’t just an academic exercise. According to data from Mayo Clinic Laboratories, whole exome and whole genome sequencing results lead to direct changes in medical management in 21% to 65% of cases, meaning they can change the treatments, monitoring, or preventive care a patient receives.
Newborn Screening
One of the most widespread applications of medical genetics is the newborn screening program. In the United States, the Recommended Uniform Screening Panel (RUSP) maintained by the Department of Health and Human Services lists over 35 core conditions that states are encouraged to screen for using a small blood sample collected from every baby shortly after birth. These conditions span metabolic disorders (like phenylketonuria and maple syrup urine disease), endocrine disorders (like congenital hypothyroidism), hemoglobin disorders (like sickle cell disease), and others including cystic fibrosis, spinal muscular atrophy, severe combined immunodeficiency, and critical congenital heart disease.
The panel also includes dozens of secondary conditions that may be detected during screening. The logic behind newborn screening is straightforward: many of these conditions are treatable or manageable if caught early, but can cause serious, irreversible damage if missed. Disorders are chosen for the panel based on evidence that early detection provides a clear benefit, that reliable screening is feasible, and that effective treatments exist.
Gene Therapy and Emerging Treatments
Medical genetics has moved well beyond diagnosis. Gene therapy, once a theoretical concept, is now a clinical reality for certain conditions. In 2023, the FDA approved the first therapies using CRISPR gene-editing technology, both for sickle cell disease. One approach edits a patient’s own blood stem cells to boost production of fetal hemoglobin, a form of hemoglobin that prevents red blood cells from deforming into the sickle shape that blocks blood flow. In clinical trials, 29 out of 31 evaluable patients (93.5%) who received this treatment went at least 12 consecutive months without a severe pain crisis.
A second approved therapy uses a different technique: a viral delivery vehicle inserts a gene that produces a modified hemoglobin functioning like the normal adult version. In that trial, 88% of patients achieved complete resolution of pain crises between 6 and 18 months after treatment. Both therapies are one-time infusions made from the patient’s own modified stem cells, though they do require intensive chemotherapy beforehand to clear existing bone marrow and make room for the corrected cells.
Who Works in Medical Genetics
Two key professionals you’re likely to encounter are medical geneticists and genetic counselors. Medical geneticists are physicians who completed medical school, a residency (often in pediatrics or internal medicine), and additional fellowship training in genetics. They are board-certified through the American Board of Medical Genetics and Genomics and can perform physical exams, order and interpret genetic tests, make diagnoses, and create individualized treatment plans.
Genetic counselors hold a master’s degree in genetic counseling and earn certification through a separate credentialing process. They play a central role in reviewing family histories, explaining test results, and helping families understand inheritance risks and options. The key distinction is that genetic counselors cannot perform physical exams or create medical management plans beyond what’s already established in published guidelines. In practice, geneticists and counselors work closely together, and many patients interact more with their genetic counselor than with the physician.
Legal Protections for Genetic Information
If you’re considering genetic testing, it’s worth knowing that federal law provides specific protections against genetic discrimination. The Genetic Information Nondiscrimination Act (GINA) has two main components. Title I prevents health insurers from using genetic information to make coverage or pricing decisions. Title II makes it illegal for employers to use genetic information in hiring, firing, pay, promotions, or any other employment decision.
Under GINA, “genetic information” is defined broadly. It includes your own genetic test results, the genetic test results of your family members, your family medical history, and even your participation in genetic research. Employers are restricted from requesting, requiring, or purchasing this information, and harassing someone based on their genetic information is explicitly prohibited. These protections exist because genetic information reflects risk, not current health, and cannot tell an employer anything about a person’s ability to do their job. One notable gap: GINA does not cover life insurance, disability insurance, or long-term care insurance, so genetic test results could potentially affect those policies.